317 related articles for article (PubMed ID: 25249503)
1. Physiological effects and therapeutic potential of proinsulin C-peptide.
Yosten GL; Maric-Bilkan C; Luppi P; Wahren J
Am J Physiol Endocrinol Metab; 2014 Dec; 307(11):E955-68. PubMed ID: 25249503
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?
Nordquist L; Johansson M
Vasc Health Risk Manag; 2008; 4(6):1283-8. PubMed ID: 19337542
[TBL] [Abstract][Full Text] [Related]
3. The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms.
Yaribeygi H; Maleki M; Sathyapalan T; Sahebkar A
Life Sci; 2019 Nov; 237():116950. PubMed ID: 31605709
[TBL] [Abstract][Full Text] [Related]
4. Intracellular signalling by C-peptide.
Hills CE; Brunskill NJ
Exp Diabetes Res; 2008; 2008():635158. PubMed ID: 18382618
[TBL] [Abstract][Full Text] [Related]
5. C-peptide: much more than a byproduct of insulin biosynthesis.
Marques RG; Fontaine MJ; Rogers J
Pancreas; 2004 Oct; 29(3):231-8. PubMed ID: 15367890
[TBL] [Abstract][Full Text] [Related]
6. The actions of C-peptide in HEK293 cells are dependent upon insulin and extracellular glucose concentrations.
Rossiter JL; Redlinger LJ; Kolar GR; Samson WK; Yosten GLC
Peptides; 2022 Apr; 150():170718. PubMed ID: 34954230
[TBL] [Abstract][Full Text] [Related]
7. C-peptide makes a comeback.
Wahren J; Jörnvall H
Diabetes Metab Res Rev; 2003; 19(5):345-7. PubMed ID: 12951641
[TBL] [Abstract][Full Text] [Related]
8. Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.
Kolar GR; Grote SM; Yosten GL
J Intern Med; 2017 Jan; 281(1):25-40. PubMed ID: 27306986
[TBL] [Abstract][Full Text] [Related]
9. Molecular effects of proinsulin C-peptide.
Johansson J; Ekberg K; Shafqat J; Henriksson M; Chibalin A; Wahren J; Jörnvall H
Biochem Biophys Res Commun; 2002 Aug; 295(5):1035-40. PubMed ID: 12135597
[TBL] [Abstract][Full Text] [Related]
10. C-peptide in diabetes diagnosis and therapy.
Ludvigsson J
Front Biosci (Elite Ed); 2013 Jan; 5(1):214-23. PubMed ID: 23276983
[TBL] [Abstract][Full Text] [Related]
11. Proinsulin: recent observations and controversies.
Mackin RB
Cell Mol Life Sci; 1998 Jul; 54(7):696-702. PubMed ID: 9711235
[TBL] [Abstract][Full Text] [Related]
12. Proinsulin and C-peptide: a review.
Kitabchi AE
Metabolism; 1977 May; 26(5):547-87. PubMed ID: 403392
[TBL] [Abstract][Full Text] [Related]
13. Effects of proinsulin C-peptide on oxygen transport, uptake and utilization in insulinopenic diabetic subjects--a review.
Nordquist L; Stridh S
Adv Exp Med Biol; 2009; 645():193-8. PubMed ID: 19227471
[TBL] [Abstract][Full Text] [Related]
14. Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects.
Shafqat J; Melles E; Sigmundsson K; Johansson BL; Ekberg K; Alvelius G; Henriksson M; Johansson J; Wahren J; Jörnvall H
Cell Mol Life Sci; 2006 Aug; 63(15):1805-11. PubMed ID: 16845606
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
[TBL] [Abstract][Full Text] [Related]
16. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
Walenciak Ł; Fendler W; Młynarski W
Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
[TBL] [Abstract][Full Text] [Related]
17. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
Bhatt MP; Lim YC; Ha KS
Cardiovasc Res; 2014 Nov; 104(2):234-44. PubMed ID: 25239825
[TBL] [Abstract][Full Text] [Related]
18. Insulin glulisine: viewpoints.
Dailey G; Ahmadian M; Duckworth WC; Eckel J
Drugs; 2006; 66(6):870-2. PubMed ID: 16706559
[No Abstract] [Full Text] [Related]
19. Mechanistic understanding of insulin receptor modulation: Implications for the development of anti-diabetic drugs.
Yunn NO; Kim J; Kim Y; Leibiger I; Berggren PO; Ryu SH
Pharmacol Ther; 2018 May; 185():86-98. PubMed ID: 29262294
[TBL] [Abstract][Full Text] [Related]
20. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
Luppi P; Kallas Å; Wahren J
Diabetes Metab Res Rev; 2013 Jul; 29(5):357-62. PubMed ID: 23463541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
